The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move reflecting how exporters are capitalizing on currency fluctuations, Honda Motor reported strong financial results and raised its annual outlook after returning to profit growth for the first time in six quarters. The company posted GAAP EPS of ¥115.84, with total revenue reaching ¥6061.51B for the period. According to reports, the weakness of the Japanese yen played a pivotal role in bolstering profit margins and supporting the company's upgraded guidance.
Alongside the automotive sector results, Astellas Pharma demonstrated steady financial performance, reporting EPS of ¥78.96 on revenue of ¥640.91B. While Honda upgraded its full-year expectations, Astellas Pharma chose to reaffirm its existing financial projections for fiscal year 2027. These results arrive as Japanese markets monitor the impact of monetary dynamics on the performance of major corporations across diverse sectors.
Regarding market performance, Honda (7267.T) stood at ¥1623 at the close of August 5, 2026, while Astellas Pharma (4503.T) closed at ¥2168.5 on August 4, 2026. Investors are watching for continued currency tailwinds in the coming quarter, particularly following recent economic data showing Japanese Consumer Confidence reached 34.9 at the end of July.